Search Results for "Mark Trudeau Leaving Bayer"
Original Source: Bayer USA Foundation
The Bayer USA Foundation is an endowed 501(c)(3) entity and is the primary source of Bayer Corporationâs philanthropy in the United States. With a programmatic focus on the environment and sustainability; education and workforce development; arts and culture; and health and human services, the foundation creates and supports organizations that improve communities in which Bayer employees live and work, as well as society at large. The Bayer USA Foundatio...
Matching Channels
Rivaroxaban is the most broadly indicated novel oral anticoagulant and is marketed under the brand name Xarelto®. To date, Xarelto has been approved for use in the following indications across t...
Xofigo (radium-223 dichloride)
New treatment for castration-resistant prostate cancer (CRPC) patients with bone metastases. Xofigo shown in a pivotal phase III trial to significantly improve overall survival. Xofigo® with...
Lemtrada (alemtuzumab) is being developed by Sanofi in collaboration with Bayer Healthcare for the treatment of relapsing multiple sclerosis.
Veryan has developed three dimensional (3D) stent technology based upon a helical shape that may be applied to a self-expanding stent platform. The initial objective was to investigate the presen...
Matching News
Trudeau researchers identify unforeseen regulation of the anti-bacterial immune response
(Trudeau Institute) New research from the laboratory of Dr. Andrea Cooper at the Trudeau Institute, just published in the European Journal of Immunology, holds promise for the improved prevention and...
Return to top 50 pharma list Summary Website: Bayer | Bayer Healthcare | Bayer CropScience | Bayer MaterialScience Headquarters: Leverkusen, Germany Ticker: BAYN (Dax, Germany) SEC: n/a...
Bayer honours Canadians who have made a mark on society through science and innovation
Scientists and innovators have guided every step in Bayer's 150-year journey to becoming a global leader in healthcare, crop and material sciences. As it marks its 150th anniversary this year, Bayer a...
Bayer healthcare head returns to Novartis as Chairman
FRANKFURT, Jan 23 (Reuters) - Bayer AG said the head of its healthcare division, Joerg Reinhardt, is leaving to join his former employer Novartis as chairman.
Trudeau Institute study holds promise for improved prevention and treatment of bacterial infections
New research from the laboratory of Dr. Andrea Cooper at the Trudeau Institute, just published in the European Journal of Immunology, holds promise for the improved prevention and treatment of bacteri...
Saranac Lake, New York (PRWEB) December 20, 2012 Trudeau Institute faculty member Stephen T. Smiley, Ph.D. , has been awarded a grant to evaluate new strategies for improving patient survival af...
As Healthcare Leader Exits, Bayer’s Pharma Business Quietly Thrives
While Bayer’s pharmaceutical business, tucked into an enormous conglomerate, sometimes flies under the radar of investors, it has had an exceptionally strong year. The group that Jorg Reinhardt is l...
Bayer-Aktie: Bayer HealthCare erwirbt US-Tiergesundheitsgeschäft von Teva
Leverkusen - Die zur Bayer AG ISIN DE000BAY0017/ WKN BAY001) gehörende Bayer HealthCare verstärkt ihre Marktposition im Bereich Tiergesundheit in den USA mit einem Zukauf. Wie aus einer am Freitag ....
Matching PubMed Articles
A review of the determination of organic compounds in Bayer process liquors.
Bayer process liquors present a difficult and complex matrix to the analytical chemist, and the history of the application of modern analytical techniques to this problem is a case study in innovation...
Editorial: the importance of chemistry for the future of the pharma industry.
"Collaborative innovation"-regaining the edge in drug discovery.
